[1] |
Nunn A et al. Eur J Nucl Med,1995;22(3):265.
|
[2] |
Patterson RE et al. J Nucl Med,1995;36:1086.
|
[3] |
Archer CM et al. J Ncul Biol Med,1994;38(3):473.
|
[4] |
Schneider RF et al. Quarterly J Nucl Med,1995;39(1):41.
|
[5] |
Edwards DI. J Antimicrob Chemother,1993;31:9.
|
[6] |
Groshar D et al. J Nucl Med,1993;34:885.
|
[7] |
Al-Arafaj A et al. Eur J Nucl Med,1994;21:1338.
|
[8] |
Yeh SH et al. J Nucl Med,1994;35:205P(abs).
|
[9] |
Grunbaum Z et al. J Nucl Med,1987;28:68.
|
[10] |
Jerabeck PA et al. Int J Radiat Appl Instrum[A],1986;37:599.
|
[11] |
Rasey JS et al. Radiat Res,1987;111:292.
|
[12] |
Biskupiak JE et al. J Med Chem,1991;34:2165.
|
[13] |
Wiebe LI et al. Nuklearmedizin,1984;23:63.
|
[14] |
Linder KE et al. J Med Chem,1994;37:9.
|
[15] |
Mannan RH et al. J Nucl Med,1991;32:1764.
|
[16] |
Linker KE et al. Bioconj Chem,1993;4:326.
|
[17] |
Raju N et al. Tetrahedron,1993;48:10233.
|
[18] |
Predegas JL et al. Biochem Pharmacol,1991;42:2387.
|
[19] |
Linder KE et al. J Nucl Med,1994;35:18P(abs).
|
[20] |
Rumsey WL et al. Potential of nitroimidazoleas markers of hypoxia in heart. In:Vaupel Pet al,eds. Oxygen transport to tissue. NewYork:Plenum;1994:263-270.
|
[21] |
Di Rocco RJ et al. J Cereb Blood Flow Metab,1993;13:755.
|
[22] |
Chan YW et al. J Nucl Med,1994;35:152 P(abs).
|
[23] |
World Patent Appl. WO94089-A1,Amersham Int. plc.
|
[24] |
Linder KE et al. J Labelled Compd Radiopharm,1995;37:202.
|
[25] |
Stone CK et al. J Nucl Med,1995;36(5):138P(abs).
|
[26] |
Ramalingam K et al. J Nucl Med,1994;35(5):260 P (abs).
|
[27] |
Zhang Z et al. J Labelled Compd Radiopharm,1995;37:205.
|
[28] |
Zhang Z et al. J Nucl Med,1994;38:472.
|
[29] |
Okada RD et al. Eur J Nucl Med,1996;23:443.
|
[30] |
Kuczynski B et al. J Nucl Cardio,1995;4:S28(abs).
|